178 related articles for article (PubMed ID: 10959036)
1. The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk.
Griffin WS; Nicoll JA; Grimaldi LM; Sheng JG; Mrak RE
Exp Gerontol; 2000 Jul; 35(4):481-7. PubMed ID: 10959036
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1, neuroinflammation, and Alzheimer's disease.
Mrak RE; Griffin WS
Neurobiol Aging; 2001; 22(6):903-8. PubMed ID: 11754997
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease.
Griffin WS; Mrak RE
J Leukoc Biol; 2002 Aug; 72(2):233-8. PubMed ID: 12149413
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 and the immunogenetics of Alzheimer disease.
Mrak RE; Griffin WS
J Neuropathol Exp Neurol; 2000 Jun; 59(6):471-6. PubMed ID: 10850859
[TBL] [Abstract][Full Text] [Related]
5. Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism.
Grimaldi LM; Casadei VM; Ferri C; Veglia F; Licastro F; Annoni G; Biunno I; De Bellis G; Sorbi S; Mariani C; Canal N; Griffin WS; Franceschi M
Ann Neurol; 2000 Mar; 47(3):361-5. PubMed ID: 10716256
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice.
Sheng JG; Mrak RE; Bales KR; Cordell B; Paul SM; Jones RA; Woodward S; Zhou XQ; McGinness JM; Griffin WS
J Neurochem; 2000 Jan; 74(1):295-301. PubMed ID: 10617132
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis.
Sheng JG; Ito K; Skinner RD; Mrak RE; Rovnaghi CR; Van Eldik LJ; Griffin WS
Neurobiol Aging; 1996; 17(5):761-6. PubMed ID: 8892349
[TBL] [Abstract][Full Text] [Related]
8. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.
Mrak RE; Sheng JG; Griffin WS
J Neuropathol Exp Neurol; 1996 Mar; 55(3):273-9. PubMed ID: 8786385
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.
Griffin WS; Sheng JG; Roberts GW; Mrak RE
J Neuropathol Exp Neurol; 1995 Mar; 54(2):276-81. PubMed ID: 7876895
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 gene cluster polymorphisms and risk of Alzheimer's disease in Chinese Han population.
Li XQ; Zhang JW; Zhang ZX; Chen D; Qu QM
J Neural Transm (Vienna); 2004 Sep; 111(9):1183-90. PubMed ID: 15338333
[TBL] [Abstract][Full Text] [Related]
11. Association of interleukin-1 gene polymorphisms with Alzheimer's disease.
Nicoll JA; Mrak RE; Graham DI; Stewart J; Wilcock G; MacGowan S; Esiri MM; Murray LS; Dewar D; Love S; Moss T; Griffin WS
Ann Neurol; 2000 Mar; 47(3):365-8. PubMed ID: 10716257
[TBL] [Abstract][Full Text] [Related]
12. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
[TBL] [Abstract][Full Text] [Related]
13. Association of an interleukin-1beta gene polymorphism at position -511 with Alzheimer's disease.
Ehl C; Kölsch H; Ptok U; Jessen F; Schmitz S; Frahnert C; Schlösser R; Rao ML; Maier W; Heun R
Int J Mol Med; 2003 Feb; 11(2):235-8. PubMed ID: 12525884
[TBL] [Abstract][Full Text] [Related]
14. Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages.
Sheng JG; Mrak RE; Griffin WS
J Neuropathol Exp Neurol; 1997 Mar; 56(3):285-90. PubMed ID: 9056542
[TBL] [Abstract][Full Text] [Related]
15. Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease.
Rebeck GW
Neurosci Lett; 2000 Oct; 293(1):75-7. PubMed ID: 11065142
[TBL] [Abstract][Full Text] [Related]
16. Association of an interleukin 1 alpha polymorphism with Alzheimer's disease.
Du Y; Dodel RC; Eastwood BJ; Bales KR; Gao F; Lohmüller F; Müller U; Kurz A; Zimmer R; Evans RM; Hake A; Gasser T; Oertel WH; Griffin WS; Paul SM; Farlow MR
Neurology; 2000 Aug; 55(4):480-3. PubMed ID: 10953177
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease.
Sciacca FL; Ferri C; Licastro F; Veglia F; Biunno I; Gavazzi A; Calabrese E; Martinelli Boneschi F; Sorbi S; Mariani C; Franceschi M; Grimaldi LM
Neurobiol Aging; 2003 Nov; 24(7):927-31. PubMed ID: 12928052
[TBL] [Abstract][Full Text] [Related]
18. [Expression of cytokine IL-1α and S100β in different types of plaques in Alzheimer's disease].
Yao JJ; He SR; Chen L; Yang L; Qiao XB; Zhang W; Du J; Liu DG
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):581-4. PubMed ID: 22177239
[TBL] [Abstract][Full Text] [Related]
19. Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD?
Green EK; Harris JM; Lemmon H; Lambert JC; Chartier-Harlin MC; St Clair D; Mann DM; Iwatsubo T; Lendon CL
Neurology; 2002 May; 58(10):1566-8. PubMed ID: 12034804
[TBL] [Abstract][Full Text] [Related]
20. Association of IL-1 RN*2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer's disease.
Bosco P; Guéant-Rodríguez RM; Anello G; Romano A; Namour B; Spada RS; Caraci F; Tringali G; Ferri R; Guéant JL
J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):1036-8. PubMed ID: 15201366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
